Longitudinal Brain Atrophy Rates in Presymptomatic Carriers of Genetic Frontotemporal Dementia

BACKGROUND AND OBJECTIVES: It is important to identify at what age brain atrophy rates in genetic frontotemporal dementia (FTD) start to accelerate and deviate from normal aging effects to find the optimal starting point for treatment. We investigated longitudinal brain atrophy rates in the presympt...

Descripción completa

Detalles Bibliográficos
Autores principales: Poos, Jackie M., Grandpierre, Leonie D. M., van der Ende, Emma L., Panman, Jessica L., Papma, Janne M., Seelaar, Harro, van den Berg, Esther, van 't Klooster, Ronald, Bron, Esther, Steketee, Rebecca, Vernooij, Meike W., Pijnenburg, Yolande A. L., Rombouts, Serge A. R. B., van Swieten, John, Jiskoot, Lize C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757869/
https://www.ncbi.nlm.nih.gov/pubmed/36288997
http://dx.doi.org/10.1212/WNL.0000000000201292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757869/
https://www.ncbi.nlm.nih.gov/pubmed/36288997
http://dx.doi.org/10.1212/WNL.0000000000201292

Ejemplares similares